Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection.
Galan LEB, Santos NMD, Asato MS, Araújo JV, de Lima Moreira A, Araújo AMM, Paiva ADP, Portella DGS, Marques FSS, Silva GMA, de Sousa Resende J, Tizolim MR, Santos PL, Buttenbender SF, de Andrade SB, Carbonell RCC, Da Rocha JG, de Souza RGS, da Fonseca AJ.
Galan LEB, et al. Among authors: da rocha jg.
Pathog Glob Health. 2021 Jun;115(4):235-242. doi: 10.1080/20477724.2021.1890887. Epub 2021 Mar 8.
Pathog Glob Health. 2021.
PMID: 33682640
Free PMC article.
Clinical Trial.